ArticleMedical & biological engineering & computing2022
A multi-layered hybrid model for cancer cell invasion.
Article in Medical & biological engineering & computing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 5 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this article, a hybrid model is developed based on multi-scale concept for solid tumour cell invasion into a healthy tissue. Our aim is to study the tumour heterogeneity due to the geometry of a growing tumour caused by the phenotypic transformations of cells. In this context, an early vascular growth is considered after angiogenesis. Hence, the microenvironment of the solid tumour is rich of oxygen and nutrients. It is also considered that epidermal growth factor (EGF) is distributed into the surrounding extracellular matrix (ECM) of the tumour. The developed multi-layered model consists of three layers: intracellular or subcellular, cellular, and extracellular or tissue layer. The model integrates the events that occur simultaneously in these three layers to identify the underlying diversity. Here, every cell is represented as an agent. Characteristics of an agent are controlled by its intracellular protein expressions and its surrounding microenvironment. A mature proliferative or migratory or hybrid cell agent spawn two indistinguishable children unless it may convert into other phenotype due to influence of the microenvironment. Further, a simple cell cycle model is adapted which is influenced by EGF-EGFR signalling pathway and the external oxygen and nutrients. Moreover, migratory and hybrid cells secrete several matrix degrading enzymes (MDEs) which remodel the ECM for tumour invasion locally. Several biomechanical forces are considered that simultaneously act on the cancer cells. The outcome of the model is very similar to the results reported in earlier studies. The model shows the characteristics of cancer invasion that include sustainable proliferation by ignoring growth suppressor signals and reproduction of cancer cells at abnormal proportion, restrict apoptosis, and invade into the surrounding tissue. As the simulation parameters get modified due to different biochemical and biophysical processes, the robustness of the model is determined. It is found that only a number of proliferative cells are moderately sensitive to the parameters and others are less-sensitive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.